Nadia Maria Volpato
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Research Subjects
Nadia Maria Volpato has a total of 150 co-authors. Here are the top co-authors by number of shared publications:
- Elfrides Eva Schermann Schapoval
Faculdade de Farmácia, Universidade Federal do Rio Grande do Sul, Porto Alegre, RS, Brazil
6 shared publications - Vítor Todeschini
Postgraduate Program in Pharmaceutical Sciences, Faculty of Pharmacy, Federal University of Rio Grande do Sul, 90610-000 Porto Alegre-RS, Brazil
6 shared publications - Patrizia Santi
ADDRes Lab, Department of Food and Drug, University of Parma, Parco Area delle Scienze 27/A, 43124 Parma, Italy
5 shared publications Maximiliano da Silva Sangoi
Faculty of Pharmacy, Federal University of Rio de Janeiro, Macaé, RJ, Brazil
4 shared publications- Valeria Pereira de Sousa
Laboratory for Drug and Medicine Quality Control (LabCQ), Department of Drugs and Pharmaceutics, Faculty of Pharmacy, Universidade Federal do Rio de Janeiro, Rio de Janeiro, Brazil
4 shared publications Alini Dall Cortivo Lange
3 shared publications
Latest Publications
- Open Access
- 13 February 2026
- Published by ABEC Publicacoes in Abec Meeting
- p. 1-6
Desafios na divulgação e visibilidade de periódico na área farmacêutica: experiência da Drug Analytical Research
For young journals just starting out in publishing, reaching national and international researchers is a major challenge. The objective of this work was to discuss the main challenges and strategies adopted by the journal Drug Analytical Research, established in 2017, for its dissemination. Through experience reports, based on the memories and records of the editorial board members, it was possible to list as strategies the invitations sent to researchers, the seeking for indexing in various databases and directories, as well as the use of the School of Pharmacy's social media. It is clear that a wide range of dissemination strategies should be adopted by new journals to consolidate their reputation and to reach relevant papers for publication.
- 13 February 2026
- Published by ABEC Publicacoes in Abec Meeting
- p. 1-6
Open AccessDesafios na divulgação e visibilidade de periódico na área farmacêutica: experiência da Drug Analytical Research
For young journals just starting out in publishing, reaching national and international researchers is a major challenge. The objective of this work was to discuss the main challenges and strategies adopted by the journal Drug Analytical Research, established in 2017, for its dissemination. Through experience reports, based on the memories and records of the editorial board members, it was possible to list as strategies the invitations sent to researchers, the seeking for indexing in various databases and directories, as well as the use of the School of Pharmacy's social media. It is clear that a wide range of dissemination strategies should be adopted by new journals to consolidate their reputation and to reach relevant papers for publication.
- Open Access
- 15 December 2021
- Published by Universidade Federal do Rio Grande do Sul in Drug Analytical Research
- Vol. 5 (2) , 11-16
Development and validation of a dissolution test for empagliflozin in film-coated tablets
The present study proposes a validated dissolution method for empagliflozin (EMPA) in film coated tablets. A gradual in vitro dissolution profile for this formulation was obtained using 900 mL of hydrochloric acid 0.01 M at 37 °C ± 0.5 °C as dissolution medium and USP apparatus 2 (paddle) at 50 rpm. The dissolved percentage of EMPA was quantified by ultraviolet spectrophotometric method to obtain cost technique and produce little residual solvents. Validation parameter for dissolution methodology such as the specificity, linearity, accuracy and precision were evaluated according to the international guidelines, giving results within the acceptable range. The method is linear in the range of 1 - 40 µg/mL, precise, with RSD value less than 2.62%, accurate (mean recovery 106.97%) and robust. Therefore, since no official method has been described, the proposed dissolution conditions represent a relevant contribution to evaluate the dissolution profile of coated tablet containing 25 mg of EMPA.
- 15 December 2021
- Published by Universidade Federal do Rio Grande do Sul in Drug Analytical Research
- Vol. 5 (2) , 11-16
Open AccessDevelopment and validation of a dissolution test for empagliflozin in film-coated tablets
The present study proposes a validated dissolution method for empagliflozin (EMPA) in film coated tablets. A gradual in vitro dissolution profile for this formulation was obtained using 900 mL of hydrochloric acid 0.01 M at 37 °C ± 0.5 °C as dissolution medium and USP apparatus 2 (paddle) at 50 rpm. The dissolved percentage of EMPA was quantified by ultraviolet spectrophotometric method to obtain cost technique and produce little residual solvents. Validation parameter for dissolution methodology such as the specificity, linearity, accuracy and precision were evaluated according to the international guidelines, giving results within the acceptable range. The method is linear in the range of 1 - 40 µg/mL, precise, with RSD value less than 2.62%, accurate (mean recovery 106.97%) and robust. Therefore, since no official method has been described, the proposed dissolution conditions represent a relevant contribution to evaluate the dissolution profile of coated tablet containing 25 mg of EMPA.
- Open Access
- 23 December 2019
- Published by Universidade Federal do Rio Grande do Sul in Drug Analytical Research
- Vol. 3 (2) , 46-50
Evaluation of linagliptin dissolution from tablets using HPLC and UV methods
Linagliptin (LGT) is used to reduce glucose blood levels in patients with type 2 Diabetes mellitus. The proposed conditions for a biowaiver guide can be applied due to high solubility of linagliptin in aqueous media. The aim of the present study was to develop and validate a dissolution test for 5 mg linagliptin coated tablets. After diverse dissolution procedure evaluation, the selected method was achieved using USP apparatus 1 (basket) at 75 rpm and 900 mL of citrate buffer pH 3.5 as dissolution medium. The conditions proposed by biowaiver guide were also applied to this drug, using USP apparatus 2 (paddle) and 900 mL of 0.1 M HCl, pH 4.5 acetate buffer and pH 6.8 phosphate buffer as dissolution medium. HPLC and UV spectrophotometry were used to LGT quantitation and validated for this purpose. The chromatographic and spectrophotometric methods in the dissolution context proved to be linear in 0.5 – 20.0 μg.mL-1 range, precise with RSD values less than 1.0 % and 2.0%, respectively, and accurate (mean recovery 100.29 % and 100.59%). The parameters such as specificity, linearity, accuracy, precision and robustness were according to international guidelines for both methods HPLC and UV. Dissolved linagliptin results were compared using the Student’s t-test and the data found were not significant different (P=0.068). In most dissolution conditions evaluated, LGT presented more than 85% drug dissolved from the tablets in fifteen minutes. The proposed methods can be applied for quality control of this gliptin. According to the results, linagliptin may be a biowaiver candidate.
- 23 December 2019
- Published by Universidade Federal do Rio Grande do Sul in Drug Analytical Research
- Vol. 3 (2) , 46-50
Open AccessEvaluation of linagliptin dissolution from tablets using HPLC and UV methods
Linagliptin (LGT) is used to reduce glucose blood levels in patients with type 2 Diabetes mellitus. The proposed conditions for a biowaiver guide can be applied due to high solubility of linagliptin in aqueous media. The aim of the present study was to develop and validate a dissolution test for 5 mg linagliptin coated tablets. After diverse dissolution procedure evaluation, the selected method was achieved using USP apparatus 1 (basket) at 75 rpm and 900 mL of citrate buffer pH 3.5 as dissolution medium. The conditions proposed by biowaiver guide were also applied to this drug, using USP apparatus 2 (paddle) and 900 mL of 0.1 M HCl, pH 4.5 acetate buffer and pH 6.8 phosphate buffer as dissolution medium. HPLC and UV spectrophotometry were used to LGT quantitation and validated for this purpose. The chromatographic and spectrophotometric methods in the dissolution context proved to be linear in 0.5 – 20.0 μg.mL-1 range, precise with RSD values less than 1.0 % and 2.0%, respectively, and accurate (mean recovery 100.29 % and 100.59%). The parameters such as specificity, linearity, accuracy, precision and robustness were according to international guidelines for both methods HPLC and UV. Dissolved linagliptin results were compared using the Student’s t-test and the data found were not significant different (P=0.068). In most dissolution conditions evaluated, LGT presented more than 85% drug dissolved from the tablets in fifteen minutes. The proposed methods can be applied for quality control of this gliptin. According to the results, linagliptin may be a biowaiver candidate.
- 6 March 2018
- Published by Oxford University Press (OUP) in Bulletin of the Chemical Society of Japan
- Vol. 91 (6) , 865-874
Efficient Praziquantel Encapsulation into Polymer Microcapsules and Taste Masking Evaluation Using an Electronic Tongue
Taste masking is an important strategy for improving adherence of patients, especially children, who have to take pharmaceutical drugs with a bitter taste, as is the case of praziquantel (PZQ) used to treat schistosomiasis. In this work, a modified interfacial polymer deposition method was used to prepare polymer microcapsules and microspheres to encapsulate PZQ, where formulations were optimized to fulfill the stringent requirements for controlled drug release. In vitro release tests confirmed the suitability of the formulation with microcapsules of the anionic copolymer L30D, in which the loading of PZQ was larger than 90% in solutions that were stable at low pH but released PZQ under enteric conditions. We also show that the encapsulation was effective in terms of masking PZQ taste through the analysis with an electronic tongue.
- 6 March 2018
- Published by Oxford University Press (OUP) in Bulletin of the Chemical Society of Japan
- Vol. 91 (6) , 865-874
Efficient Praziquantel Encapsulation into Polymer Microcapsules and Taste Masking Evaluation Using an Electronic Tongue
Taste masking is an important strategy for improving adherence of patients, especially children, who have to take pharmaceutical drugs with a bitter taste, as is the case of praziquantel (PZQ) used to treat schistosomiasis. In this work, a modified interfacial polymer deposition method was used to prepare polymer microcapsules and microspheres to encapsulate PZQ, where formulations were optimized to fulfill the stringent requirements for controlled drug release. In vitro release tests confirmed the suitability of the formulation with microcapsules of the anionic copolymer L30D, in which the loading of PZQ was larger than 90% in solutions that were stable at low pH but released PZQ under enteric conditions. We also show that the encapsulation was effective in terms of masking PZQ taste through the analysis with an electronic tongue.
- Open Access
- 1 September 2016
- Published by FapUNIFESP (SciELO) in Brazilian Journal of Pharmaceutical Sciences
- Vol. 52 (3) , 483-491
In vitro evaluation of cutaneous penetration of acyclovir from semisolid commercial formulations and relation with its effective antiviral concentration
The evaluation of drug permeation/penetration of semisolid formulations into animal skin can be useful to supplement the pharmaceutical equivalence. This paper describes the in vitro assessment of acyclovir (ACV) into porcine skin from commercial formulations with etermination of drug concentration in different layers of cutaneous tissue to correlate with effective antiviral concentration in order to improve the equivalence decision. Studies were conducted using Franz cells and porcine skin. Selected pharmaceutical creams containing ACV had identical (reference and generic) and different (similar) excipients. A software program was employed for the simulation of antiviral effectiveness in the skin. Regarding ACV skin penetration, the first batch of the generic product showed a significant difference from reference and similar products, while in the second batch all products demonstrated equivalent drug penetration in the skin. Simulation studies suggest that formulations analysed exhibit a pharmacological effect even when in contact with Herpes simplex strains of high IC50 (inhibitory concentration required to reduce viral replication by 50%). According to results, it can be assumed that the in vitro cutaneous permeation/penetration study does not supply sensitivity information regarding small alterations of ACV semisolid formulations due to the variability inherent to the method, although it can be relevant to pharmaceutical equivalence studies in the development of semisolid products.
- 1 September 2016
- Published by FapUNIFESP (SciELO) in Brazilian Journal of Pharmaceutical Sciences
- Vol. 52 (3) , 483-491
Open AccessIn vitro evaluation of cutaneous penetration of acyclovir from semisolid commercial formulations and relation with its effective antiviral concentration
The evaluation of drug permeation/penetration of semisolid formulations into animal skin can be useful to supplement the pharmaceutical equivalence. This paper describes the in vitro assessment of acyclovir (ACV) into porcine skin from commercial formulations with etermination of drug concentration in different layers of cutaneous tissue to correlate with effective antiviral concentration in order to improve the equivalence decision. Studies were conducted using Franz cells and porcine skin. Selected pharmaceutical creams containing ACV had identical (reference and generic) and different (similar) excipients. A software program was employed for the simulation of antiviral effectiveness in the skin. Regarding ACV skin penetration, the first batch of the generic product showed a significant difference from reference and similar products, while in the second batch all products demonstrated equivalent drug penetration in the skin. Simulation studies suggest that formulations analysed exhibit a pharmacological effect even when in contact with Herpes simplex strains of high IC50 (inhibitory concentration required to reduce viral replication by 50%). According to results, it can be assumed that the in vitro cutaneous permeation/penetration study does not supply sensitivity information regarding small alterations of ACV semisolid formulations due to the variability inherent to the method, although it can be relevant to pharmaceutical equivalence studies in the development of semisolid products.
- Open Access
- 1 February 2016
- Published by Elsevier in Journal of Pharmaceutical Analysis
- Vol. 6 (1) , 49-55
Dissolution method for delapril and manidipine combination tablets based on an absorption profile of manidipine
- 1 February 2016
- Published by Elsevier in Journal of Pharmaceutical Analysis
- Vol. 6 (1) , 49-55
Open AccessDissolution method for delapril and manidipine combination tablets based on an absorption profile of manidipine
- 15 July 2015
- Published by Taylor & Francis in Journal of Liquid Chromatography & Related Technologies
- Vol. 38 (13) , 1333-1342
Delapril and Manidipine Main Degradation Products: LC-UV and LC-ESI-MS Evaluations, Decay Kinetic, andin vitroCytotoxicity Studies
A simple, stability-indicating, and compatible method by liquid chromatography with ultraviolet (LC-UV) and mass spectrometry (LC-MS) detections was developed for the evaluation of delapril (DEL) and manidipine (MAN) degradation products formed under alkaline and photolytic forced conditions, respectively. The chromatographic separation of all compounds was obtained within 7 min and carried out on a C18 column with mobile-phase composed by ammonium acetate and acetonitrile for both techniques. Thereby, the main degradation products detected were studied by LC coupled to electrospray ionization mass spectrometry (LC-ESI-MS). Based on retention times and molecular weight confirmation, a comprehensive degradation pathway for both drugs and the identity of its major products formed could be suggested, without complicated isolation or purification processes. The degradation kinetics of the drugs was also evaluated and could be best described as first-order process for DEL (R2 = 0.9991) and zero-order process for MAN (R2 = 0.9867). Furthermore, no evidence of cytotoxicity in human mononuclear cells was observed for DEL and MAN degraded samples. The proposed LC-UV method was successfully validated according ICH guidelines and thus helping to improve the quality control of pharmaceuticals.
- 15 July 2015
- Published by Taylor & Francis in Journal of Liquid Chromatography & Related Technologies
- Vol. 38 (13) , 1333-1342
Delapril and Manidipine Main Degradation Products: LC-UV and LC-ESI-MS Evaluations, Decay Kinetic, andin vitroCytotoxicity Studies
A simple, stability-indicating, and compatible method by liquid chromatography with ultraviolet (LC-UV) and mass spectrometry (LC-MS) detections was developed for the evaluation of delapril (DEL) and manidipine (MAN) degradation products formed under alkaline and photolytic forced conditions, respectively. The chromatographic separation of all compounds was obtained within 7 min and carried out on a C18 column with mobile-phase composed by ammonium acetate and acetonitrile for both techniques. Thereby, the main degradation products detected were studied by LC coupled to electrospray ionization mass spectrometry (LC-ESI-MS). Based on retention times and molecular weight confirmation, a comprehensive degradation pathway for both drugs and the identity of its major products formed could be suggested, without complicated isolation or purification processes. The degradation kinetics of the drugs was also evaluated and could be best described as first-order process for DEL (R2 = 0.9991) and zero-order process for MAN (R2 = 0.9867). Furthermore, no evidence of cytotoxicity in human mononuclear cells was observed for DEL and MAN degraded samples. The proposed LC-UV method was successfully validated according ICH guidelines and thus helping to improve the quality control of pharmaceuticals.
- 1 January 2015
- Published by Dissolution Technologies in Dissolution Technologies
- Vol. 22 (2) , 24-33
Development of a Dissolution Test for Extended-Release Bromopride Pellets with In Vivo–In Vitro Correlation
- 1 January 2015
- Published by Dissolution Technologies in Dissolution Technologies
- Vol. 22 (2) , 24-33
Development of a Dissolution Test for Extended-Release Bromopride Pellets with In Vivo–In Vitro Correlation
- 1 February 2014
- Published by IMR Press in Die Pharmazie
- Vol. 69 (2) , 86-91
Capillary zone electrophoresis for determination of vildagliptin (a DPP-4 inhibitor) in pharmaceutical formulation and comparative study with HPLC
A stability-indicating capillary zone electrophoresis (CZE) method was validated for the determination of vildagliptin (VLG) in pharmaceutical dosage forms using ranitidine hydrochloride (RH) as internal standard. The CZE method was carried out in a fused silica capillary (64.5 cm total length and 56.0 cm effective length, 50 m i. d.) by applying a potential of 25 kV (positive polarity), hydrodynamic injection by 50 mbar for 5 s and the temperature of the capillary cartridge was 25 ° C. The selected background electrolyte (BGE) consisted of 25 mM potassium phosphate (pH 8.0) with UV/PDA detection at 207 nm. The electrophoretic separation was obtained within 6 min and was linear in the range of 50–200 μg/mL (r = 0.9994). The specificity and the stability-indicating capability were demonstrated through degradation studies, which also showed that there was no interference of the formulation excipients. The method was validated in accordance to ICH guidelines acceptance criteria for specificity, linearity, precision, accuracy, robustness and system suitability. The proposed method was compared with HPLC method previously validated for this drug, and statistical analysis showed no significant difference between the methods.
- 1 February 2014
- Published by IMR Press in Die Pharmazie
- Vol. 69 (2) , 86-91
Capillary zone electrophoresis for determination of vildagliptin (a DPP-4 inhibitor) in pharmaceutical formulation and comparative study with HPLC
A stability-indicating capillary zone electrophoresis (CZE) method was validated for the determination of vildagliptin (VLG) in pharmaceutical dosage forms using ranitidine hydrochloride (RH) as internal standard. The CZE method was carried out in a fused silica capillary (64.5 cm total length and 56.0 cm effective length, 50 m i. d.) by applying a potential of 25 kV (positive polarity), hydrodynamic injection by 50 mbar for 5 s and the temperature of the capillary cartridge was 25 ° C. The selected background electrolyte (BGE) consisted of 25 mM potassium phosphate (pH 8.0) with UV/PDA detection at 207 nm. The electrophoretic separation was obtained within 6 min and was linear in the range of 50–200 μg/mL (r = 0.9994). The specificity and the stability-indicating capability were demonstrated through degradation studies, which also showed that there was no interference of the formulation excipients. The method was validated in accordance to ICH guidelines acceptance criteria for specificity, linearity, precision, accuracy, robustness and system suitability. The proposed method was compared with HPLC method previously validated for this drug, and statistical analysis showed no significant difference between the methods.